Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001169245-23-000028
Filing Date
2023-05-19
Accepted
2023-05-19 16:16:48
Documents
1
Period of Report
2023-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_168452736752699.html 4  
1 FORM 4 wf-form4_168452736752699.xml 4 5498
  Complete submission text file 0001169245-23-000028.txt   7084
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Issuer) CIK: 0001169245 (see all company filings)

EIN.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 ELLIOTT AVE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address
Loewy Caroline M (Reporting) CIK: 0001367451 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38697 | Film No.: 23940284